AI assistant
INTEGRATED RESEARCH LIMITED — Director's Dealing 2016
Nov 27, 2016
65142_rns_2016-11-27_42c65918-5b70-4e00-908c-0eacd29a70a2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity INTEGRATED RESEARCH LIMITED
ABN 76 003 588 449
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Darc Frederick Dencker-Rasmussen |
|---|---|
| Date of last notice | 11 December 2015 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | a) Direct b) Direct c) Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
a) Performance Rights b) Ordinary Shares c) Investment held in the name of The Good Life Corporation Pty Ltd Good Life Fund A/C> |
| 28thNovember 2016 | |
| No. of securities held prior to change | a) 250,000 Performance Rights b) 279,273 Ordinary Shares c) 56,351 OrdinaryShares |
| Class | a) Performance Rights b) Ordinary Shares c) Ordinary Shares |
| Number acquired | a) 350,000 Performance Rights b) - c) - |
| Number disposed | a) 250,000 Performance Rights (expired) b) Nil c) Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
a) $0.00 b) - c) - |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | a) 350,000 Performance Rights b) 279,273 Ordinary Shares c) 56,351 OrdinaryShares |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
a) - Issue of Performance Rights under the Integrated Research Performance Rights and Option Plan. 350,000 IRIAS Employee Performance Rights granted as approved by shareholders at the 2016 Annual General Meeting held on 25 November 2016. - Cancellation of 250,000 Performance Rights which have expired as the performance target was not met. b) - c) - |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
==> picture [434 x 317] intentionally omitted <==
----- Start of picture text -----
Detail of contract Not Applicable
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
----- End of picture text -----
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required?
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
|---|---|
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3